Glycyrrhiza glabra- A PLANT FOR THE FUTURE

Varsha Sharma, R C Agrawal

Abstract


Objective: A review article on Glycyrrhiza glabra, A plant which have lots of medicinal properties. So it may be known as plant for the future. The present article is an effort to highlight the role of a few major constituents of this plant, which have multifaceted pharmacological actions and could be used as a template for designing new herbal medicines. Plants have been one of the important sources of medicines since the beginning of human cultivation. There is a growing demand for plant based medicines, health products, pharmaceuticals, food supplements etc.
Conclusion :Glycyrrhiza glabra Linn is an old age plant used in traditional medicine across the globe for its ethanopharmacological value to cure varieties of ailments from simple cough to hepatitis to more complexes like SARS and CANCER. Glycyrrhiza glabra Linn used as a mild laxative, anti-arthritic, anti-inflammatory, anti-biotic, anti-viral, anti-ulcer, anti-tissive, anti-oxidant, estrogenic, anti-diuretic, hypolipidmic agent. It is reported to contain important phytoconstituents such as glycyrrhizin, glycyrrhizinic acid, glabrin A&B, triterpene sterols, saponin, and isoflavons.


Full Text:

PDF

References


Hill AF, (1952). Economic Botany. A textbook of useful plants and plant products. 2nd edn. McGarw-Hill Book Company Inc, New-York.

Okwu DE, (1999). Flavouring properties of spices on cassava Fufu. Afr.J. Roots Tuber Crops 3(2): 19-21.

Okwu DE, (2001). Evaluation of the chemical composition of indigenous spices and flavouring Agents. Global J. Pure Appl. Sci. 7(3): 455-459.

Chopra RN, Nayar SL, and Chopra IC, (2002). Glossary of Indian Medicinal Plants. New Delhi: NISCAIR, CSIR.

Bradley PR, (ed.) (1992). British Herbal Compendium, Volume 1, BHMA, Bournemouth.

Hoffmann D, (1990). The New Holistic Herbal, Second Edition, Element, Shaftesbury.

Obolentseva GV, Litvinenko VI, Ammosov AS, et al (1999). Pharmacological and therapeutic properties of licorice preparations (a review). Pharm Chem J , 33:24-31.

Yamamura Y, Kawakami J, Santa T, et al (1992). Pharmacokinetic profile of glycerrhizin in healthy volunteers by a new high-performance liquid chromatographic method. J Pharm Sci, 81:1042-1046.

Indian Herbal Pharmacopoeia Revised New Edition, India (2002): Indian Drug Manufacturers Association IDMA; p.243-52.

The Ayurvedic Pharmacopoeia of India: Ministry of Health and Family Welfare, Department of Health, Govt. of India, Vol 1, 1st edition. p.127-8.

Ammosov S, Litvinenko VI, (2003). Triterpenoids of Plants of Glycyrrhiza L. and Meristotropis Fisch. Et Mey Genuses. Pharm Chem J. 37: 83-94.

Saxena S, (2005). Glycyrrhiza glabra: Medicine over the millennium.

Available from http:/www.sciencedirect.com. (Accessed on 2011 Jan 28)

Sheth Ashok, (2005). The Herbs of India. 1st Edition, Vol.2. Gujrat: Hi Scan Pvt. Ltd. p. 566.

Available from http:/www.sciencedirect.com.(Accessed on 2011 Jan 28)

Khare CP, (2004). Encyclopedia of Indian Medicinal Plants. New York: Springer-Verlag; p.233-5.

Chopra RN, Chopra IC, (1958). Indigenous Drugs of India. 2nd ed. Kolkata: Academic Publishers; p.183-7.

Nadkarni KM, (1976). Indian Materia Medica Mumbai: Popular Prakashan Pvt. Ltd. p.582-4.

Hattori M, Sakamoto T, Yamagishi T, et al (1985). Metabolism of glycyrrhizin by human intestinal flora. II. Isolation and characterization of human intestinal bacteria capable of metabolizing glycyrrhizin and related compounds. Chem Pharm Bull (Tokyo). 33:210‐217.

Akao T, Hattori M, et al (1991). Hydrolysis of glycyrrhizin to 18 betaglycyrrhetyl monoglucuronide by lysosomal

Sharma et al Mintage journal of Pharmaceutical & Medical Sciencesǀ15-20

Vol 2 Issue 3, July – Sep 2013 www.mintagejournals.com 19

beta‐Dglucuronidase of animal livers. Biochem Pharmacol. 41:1025‐1029.

Ploeger B, Mensinga T, Sips A, et al (2001). The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metab Rev. 33:125‐147.

Yamamura Y, Kawakami J, Santa T, et al (1992). Pharmacokinetic profile of glycerrhizin in healthy volunteers by a new highperformance liquid chromatographic method. J Pharm Sci. 81:1042‐1046.

Crance JM, Biziagos E, Passagot J, et al (1990). Inhibition of hepatitis A virus replication in vitro by antiviral compounds. J Med Virol. 31:155‐160.

Van Rossum TG, Vulto AG, Hop WC, et al (1999). Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a doubleblind, randomized, placebo‐controlled phase I/II trial. J Gastroenterol Hepatol. 14:1093‐1099.

Su XS, Chen HM, Wang LH, et al (1984). Clinical and laboratory observation on the effect of glycyrrhizin in acute and chronic viral hepatitis. J Tradit Chin Med. 4:127‐132.

Baba M, Shigeta S, (1987). Antiviral activity of glycyrrhizin against Varicella‐zoster virus in vitro. Antiviral Res. 7:99‐107.

Hattori T, Ikematsu S, Koito A, et al (1989). Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS. Antiviral Res. 11:255‐261.

Ito M, Sato A, Hirabayashi K, et al (1988). Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). Antiviral Res. 10:289‐298.

Pompei R, Flore O, Marccialis MA, et al (1979). Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature. 281:689‐690.

Partridge M, Poswillo DE, (1984). Topical carbenoxolone sodium in the management of herpes simplex infection. Br J Oral Maxillofac Surg. 22:138‐145.

Numazaki K, Umetsu M, Chiba S, (1994). Effect of glycyrrhizin in children with liver dysfunction associated with cytomegalovirus infection. Tohoku J Exp Med. 172:147‐ 153.

Armanini D, Karbowiak I, Funder JW, (1983). Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors. Clin Endocrinol (Oxf). 19:609‐612.

Okimasu E, Moromizato Y, Watanabe S, et al (1983). Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug. Acta Med Okayama. 37:385‐391.

Ohuchi K, Tsurufuji A, (1982). A study of the anti‐inflammatory mechanism of glycyrrhizin. Mino Med Rev. 27:188‐193.

Akamatsu H, Komura J, Asada Y, Niwa Y, (1991). Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation. Planta Med. 57:119‐121.

Wang ZY, Nixon DW, (2001). Licorice and cancer. Nutr Cancer. 39:1‐11.

Nagai T, Egashira T, Yamanaka Y, Kohno M, (1991). The protective effect of glycyrrhizin against injury of the liver caused by ischemia‐reperfusion. Arch Environ Contam Toxicol. 20:432‐436.

Van Rossum TG, Vulto AG, Hop WC, Schalm SW, (2001). Glycyrrhizininduced reduction of ALT in European patients with chronic hepatitis C. Am J Gastroenterol. 96:2432‐2437.

Shibata S, (2000). A drug over the millennia: pharmacognosy, chemistry and pharmacology of licorice. Yakugaku Zassi. 120:849‐862.

Hikino H, Wagner H, Farnsworth NR, (Eds) (1985). Recent research on oriental medicinal plants. In: Economic and medicinal plant research, London, Academic Press.

: 53-85.

Kamei J, Nakamura R, Ichiki H, Kubo M, (2003). Antitussive principles of Glycyrrhiza radix, a main component of Kampo preparations Bakumondo-to. E J Pharm. 69:159-163.

Sharma V, Agrawal RC, Pandey S, (2013). Phytochemical screening and determination of anti-bacterial and anti-oxidant potential of Glycyrrhiza glabra root extracts. J. Environ. Res. Develop., 7(4A): 1552-1558.

Mauricio I, Francischett B, Monterio RQ and Guimaraeas JA, (1997). Identification of Glycyrrhizin as thrombin inhibitor. Biochim Biophys Res Commun. 235: 259-263.

Mendes-Silva W, Assafim M, Ruta B, Monteiro RQ, Guimaraes JA, Zingali RB, (2003). Antithrombotic effect of Glycyrrhizin, a plant-derived thrombin inhibitor. Thromb Res. 112:93-98.

De Clercq E, (2000). Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med Res Rev. 20: 323-349.

Badam L, (1997). In vitro antiviral activity of indigenous glycyrrhizin, licorice and Glycyrrhizic acid (Sigma) on Japanese Encephalitis Virus. J Commun Dis. 29: 91-99.

Badam L, (1994). In vitro studies on the effect of glycyrrhizin from Glycyrrhizin glabra on some RNA and DNA viruses. Indian J Pharmacol. 26: 194-199.

Masoomeh MJ, Kiarash G, (2007). In vitro susceptibility of Helicobacter pylori to licorice extract. Iran. J. Pharm. Res. 6:69-72.

Adel M, Alousi LA, Salem HA, (2005). Licorice: A possible anti-inflammatory and anti-ulcer drug. AAPS Pharm. Sci. Tech. 6:74-82.

Acharaya SK, Dasarathy S, Tandon A, Joshi YK, Tandon BN, (1993). Preliminary open trial on interferon stimulator (SNMC) derived from Glycyrrhiza glabra in the treatment of subacute hepatic failure. Ind. J. Med. Res. 98: 69-74.

Sato H, Goto W, Yamamura J, Kurokawa M, Kageyama S, Takahara T, Watanabe A, Shiraki K, (1996). Therapeutic basis of Glycyrrhizin on chronic hepatitis B. Antiviral Res. 30: 171-177.

Van Rossum TG, Vulto AG, De Man RA, Brouwer JT, Schalm SW, (1998). Glycyrrhizin as a potential treatment of chronic hepatitis C. Aliment Pharmacol Ther. 12: 199-205.

Jeong HG, You HJ, Park SJ, Moon AR, (2002). Hepatoprotective effects of 18β –glycyrrhetinic acids on carbon tetrachloride-induced liver injury, inhibition of cytochrome P450 2E1 expression. Pharmacol Res. 46: 221-227.

Chan HT, Chan C, Ho JW, (2003). Inhibition of Glycyrrhizic acid on alfatoxin B1-induced cytotoxicity of hepatoma cells. Toxicology. 188: 211-217.

Kimura M, Inoue H, Hirabayahi K, Natsume H, Ogihara M, (2001). Glycyrrhizin and some analogues induce growth of primary cultured adult rat hepatocytes via epidermal growth factor receptors. Eur J Pharmacol. 431: 151-161.

Sheela ML, Ramakrishna MK, Salimath BP, (2006). Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra. Int Immunopharmacol. 6: 494–498.

Jo EH, Kim SH, Ra JC, et al (2005). Chemopreventive properties of the ethanol extract of Chinese licorice (Glycyrrhiza uralensis) root: induction of apoptosis and G1 cell cycle arrest in MCF-7 human breast cancer cells. Cancer Lett. 230: 239–247.

Salvi M, Fiore C, Armanini D, Toninello A, (2003). Glycyrrhetinic acid-induced permeability transition in rat liver mitochondria. Biochem Pharmacol. 66: 2375–2379.

Fiore C, Salvi M, Palermo M, Sinigagliab G, Armaninia D, Toninello A, (2004). On the mechanism of mitochondrial permeability transition induction by glycyrrhetinic acid. Biochim Biophys Acta. 1658: 195–201.

Yoon G, Jung YD, Cheon SH, (2005). Cytotoxic allyl retrochalcone from the roots of Glycyrrhiza inflate. Chem Pharm Bull. 53: 694–695.

Takii H, Kometani T, Nishimura T, NakaeT,Okada S, Fushiki T, (2000). Anti-diabetic effect of Glycyrrhizin in genetically diabetic KK-Ay mice. Biol Pharm Bull. 24: 484-487.

Wagner H and Jurcic K, (2002). Immunological studies of Revitonil: a phytopharmaceutical containing Echinacea purpurea and Glycyrrhiza glabra root extract. Phytomedicine. 9(5): 390–397.

Blatina LA, (2003). Chemical modification of Glycyrrhizic acid as a route to bioactive compounds for medicine. Curr. Med. Chem. 10: 155-171.

Sharma et al Mintage journal of Pharmaceutical & Medical Sciencesǀ15-20

Vol


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.